QuickMD

QuickMD is a U.S. telemedicine company focused on direct-to-consumer virtual healthcare, with addiction treatment as its core business. The company positions itself as the nation’s largest teleMAT provider and offers online medication-assisted treatment for opioid use disorder, including buprenorphine-naloxone treatment, alongside counseling and peer-support-related services. QuickMD has expanded its commercial offerings to include prescription weight-loss care using GLP-1 medicines, hormone therapy for perimenopause and menopause, urgent care, and limited in-person addiction clinics in select states. The business operates nationally through a provider network and markets affordable cash-pay, same-day access to licensed clinicians. It is a healthcare delivery company rather than a drug developer, so its "pipeline" consists of commercial service lines rather than proprietary therapeutic assets.